We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
-16.26%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
-$2.13B
(-15%)
Cap. Flow
+$457M
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
9.66%
Holding
494
New
75
Increased
149
Reduced
153
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$102M |
| 2 |
AGNC Investment
AGNC
|
+$72.1M |
| 3 |
Mid-America Apartment Communities
MAA
|
+$67.5M |
| 4 |
Constellation Brands
STZ
|
+$66.9M |
| 5 |
Diamondback Energy
FANG
|
+$57.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTRI
NutriSystem, Inc.
NTRI
|
+$72.5M |
| 2 |
Texas Capital Bancshares
TCBI
|
+$61.7M |
| 3 |
Electronic Arts
EA
|
+$48.9M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$47.2M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.05% |
| 2 | Technology | 17.64% |
| 3 | Industrials | 14.71% |
| 4 | Consumer Discretionary | 13.8% |
| 5 | Financials | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
326
DELISTED
BioTelemetry, Inc.
BEAT
| $7.44M | 0.06% |
124,589
-14,000
| -10% | -$841K |
|
327
ICU Medical
ICUI
$4.21B
| $7.33M | 0.06% |
31,923
-2,600
| -8% | -$641K |
|
328
Universal Display
OLED
$3.76B
| $7.26M | 0.06% |
77,625
-50,700
| -40% | -$5.12M |
|
|
CTRA
329
DELISTED
Coterra Energy
CTRA
| $7.21M | 0.06% |
+322,400
| New | +$7.78M |
|
330
Insperity
NSP
$2.06B
| $7.17M | 0.06% |
76,849
-1,100
| -1% | -$114K |
|
331
Norfolk Southern
NSC
$75B
| $7.14M | 0.06% |
47,775
-39,425
| -45% | -$6.48M |
|
332
Meta Platforms (Facebook)
META
$1.37T
| $7M | 0.06% |
+53,400
| New | +$7.74M |
|
333
Monro
MNRO
$421M
| $6.96M | 0.06% |
101,196
-2,500
| -2% | -$183K |
|
|
WPX
334
DELISTED
WPX Energy, Inc.
WPX
| $6.84M | 0.06% |
602,575
-521,500
| -46% | -$7.91M |
|
335
Protolabs
PRLB
$1.79B
| $6.79M | 0.06% |
60,234
-1,500
| -2% | -$185K |
|
336
Semtech
SMTC
$10.7B
| $6.71M | 0.06% |
146,371
-4,800
| -3% | -$229K |
|
337
HF Sinclair
DINO
$16.7B
| $6.67M | 0.06% |
130,575
+1,025
| +0.8% | +$62.8K |
|
338
Saic
SAIC
$4.89B
| $6.58M | 0.06% |
103,233
-71,750
| -41% | -$5M |
|
339
US Physical Therapy
USPH
$1.22B
| $6.55M | 0.06% |
63,976
-12,900
| -17% | -$1.43M |
|
340
CSX Corp
CSX
$93B
| $6.46M | 0.05% |
+312,000
| New | +$7.18M |
|
341
Patterson-UTI
PTEN
$3.74B
| $6.28M | 0.05% |
+607,125
| New | +$8.95M |
|
342
Salesforce
CRM
$148B
| $6.19M | 0.05% |
+45,200
| New | +$6.22M |
|
343
Trade Desk
TTD
$8.59B
| $5.87M | 0.05% |
506,120
-12,000
| -2% | -$150K |
|
344
Hilton Grand Vacations
HGV
$3.64B
| $5.83M | 0.05% |
221,100
-131,575
| -37% | -$3.82M |
|
345
AMN Healthcare
AMN
$1.35B
| $5.79M | 0.05% |
102,177
-4,300
| -4% | -$241K |
|
346
Thermo Fisher Scientific
TMO
$214B
| $5.62M | 0.05% |
+25,100
| New | +$5.89M |
|
|
LHCG
347
DELISTED
LHC Group LLC
LHCG
| $5.51M | 0.05% |
58,683
-300
| -0.5% | -$28.7K |
|
348
Ziff Davis
ZD
$1.94B
| $5.46M | 0.05% |
90,477
-460
| -0.5% | -$29K |
|
349
Simon Property Group
SPG
$74.7B
| $5.45M | 0.05% |
32,461
+2,387
| +8% | +$427K |
|
350
United Airlines
UAL
$40.1B
| $5.29M | 0.04% |
+63,200
| New | +$5.55M |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, Carillon Tower Advisers held 494 positions worth $11.8B, down 15% from $13.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Carillon Tower Advisers deployed $457M of net new capital in Q4 2018, opening 75 new positions and adding to 149 existing holdings. Its largest new stake was AGNC Investment: 4,047,600 shares worth $71M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Abiomed Inc, an estimated $46M trimmed.
- Carillon Tower Advisers's largest Q4 2018 buy was AGNC Investment: 4,047,600 shares worth $71M.
- Carillon Tower Advisers added most to Centene in Q4 2018, an estimated $102M increase.
- Carillon Tower Advisers's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $46M.
- Carillon Tower Advisers fully exited NutriSystem, Inc. in Q4 2018, selling an estimated $72.5M.
- Carillon Tower Advisers's ten largest holdings make up 9.7% of its $11.8B portfolio in Q4 2018.
- Carillon Tower Advisers opened 75 new positions and closed 37 in Q4 2018.
- Carillon Tower Advisers's portfolio value fell 15% quarter-over-quarter to $11.8B.
Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.